ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SERA vs ADVB // EV/EBITDA & P/E VALUATION

Sera Prognostics Inc. (Class A) (NASDAQ) VS. Advanced Biomed Inc. (NASDAQ) • 15-METRIC TALLY: SERA 3 — ADVB 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SERA VS. ADVB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SERA ADVB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -9.10% -25.90 ADVB /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 5.20% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 1/9 +3.00 SERA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.4 20.4 +28.99 SERA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $81.3M $4.4M $76.9M SERA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SERA REV ADVB REV SERA GROSS % ADVB GROSS % SERA FCF ADVB FCF
FY 2025 $81.0K $0 -50.0% — -$26.3M -$5.9M
FY 2024 $77.0K $0 -6.5% — -$14.2M -$2.2M
FY 2023 $306.0K — — — -$27.2M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SERA // BETA —
ADVB // BETA —